1.84
Ainos Inc stock is traded at $1.84, with a volume of 46,852.
It is down -3.66% in the last 24 hours and up +8.24% over the past month.
Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
See More
Previous Close:
$1.91
Open:
$1.91
24h Volume:
46,852
Relative Volume:
0.14
Market Cap:
$13.55M
Revenue:
$18,100
Net Income/Loss:
$-13.94M
P/E Ratio:
-0.6354
EPS:
-2.8959
Net Cash Flow:
$-4.38M
1W Performance:
-10.24%
1M Performance:
+8.24%
6M Performance:
-14.42%
1Y Performance:
+265.08%
Ainos Inc Stock (AIMD) Company Profile
Compare AIMD vs COHR, KEYS, GRMN, TDY, MKSI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AIMD
Ainos Inc
|
1.84 | 14.07M | 18,100 | -13.94M | -4.38M | -2.8959 |
|
COHR
Coherent Corp
|
413.84 | 75.33B | 6.60B | 452.58M | -538.24M | 2.0946 |
|
KEYS
Keysight Technologies Inc
|
356.94 | 59.93B | 6.09B | 1.07B | 1.36B | 6.0693 |
|
GRMN
Garmin Ltd
|
238.17 | 45.92B | 7.46B | 1.74B | 1.45B | 8.9685 |
|
TDY
Teledyne Technologies Inc
|
628.34 | 29.00B | 6.22B | 933.70M | 1.05B | 19.76 |
|
MKSI
Mks Inc
|
375.32 | 24.02B | 4.07B | 328.00M | 380.00M | 4.7842 |
Ainos Inc Stock (AIMD) Latest News
Ainos Inc. (AIMD) Holds Steady Near Key Support as Small Decline Tests Recent RangeSingle Stock ETF - newsline.com
Ainos Inc. (AIMD) Q1 2025 Earnings: No Revenue Reported, EPS Loss Widens; Stock FlatEBITDA Estimate Trend - newsline.com
Ainos Inc. Q1 2025 Earnings: Net Loss of -$0.21 Per Share; Stock Declines 2.34% Amid No Revenue Disclosure - newsline.com
AIMD: Digitizing scent as a new AI data layer is driving early adoption in manufacturing and healthcare - TradingView
AIMD: Digitizing scent as AI data is unlocking new intelligence for industry and healthcare - TradingView
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Ainos Inc. Warrants (AIMDW) Hold Steady at $0.13 Amid Narrow Trading RangeHagopian Line - newsline.com
Ainos director buys $7,174 in common stock By Investing.com - Investing.com Australia
Ainos (AIMD) director reports 3,500-share open-market purchase through spouse - Stock Titan
Ainos Releases 2026 Mid-Year CEO Letter to Shareholders - Black Hills Pioneer
Ainos stock rises on 499% revenue growth, AI expansion By Investing.com - Investing.com South Africa
Ainos stock rises on 499% revenue growth, AI expansion - Investing.com
Ainos Inc. ($AIMD): Using AI to Detect Contamination in Semiconductor Fabs - Newswire.com
VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations - Black Hills Pioneer
Ainos (AIMD) director buys 2,000 shares in indirect open-market trade - Stock Titan
Ainos highlights third-party report on AI Nose expansion By Investing.com - Investing.com India
Ainos highlights third-party report on AI Nose expansion - Investing.com
Hospitals test 'Smell AI' in ERs to study crowding and infection risks - Stock Titan
Ainos Q1 2025 Earnings: EPS Misses as Company Posts Net Loss Without RevenueQuarterly Earnings - newsline.com
Ainos Sinks on Release of New Article - Baystreet.ca
Ainos Begins Clinical Study of Smell AI Technology at National Taiwan University Hospital - geneonline.com
Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study - ACCESS Newswire
Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis - ACCESS Newswire
Ainos (NASDAQ: AIMD) director buys 250 shares via spouse account - Stock Titan
Hospital tests ‘Smell AI’ to flag ER overcrowding and infection risks - Stock Titan
Ainos shares rise 5% on push into healthcare AI - MSN
VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence - ACCESS Newswire
12 Information Technology Stocks Moving In Friday's After-Market SessionAinos (NASDAQ:AIMD), Astrotech - Benzinga
Ainos (AIMD) director adds 2,000 indirect shares via spouse - Stock Titan
Ainos Inc. Warrants (AIMDW) Drop 12.5% as Penny Stock Territory Tests SupportTick Index - The Legal Advocate
Ainos Inc. Warrants (AIMDW) Hold Steady at $0.12 as Consolidation ContinuesSpring Pattern - newsline.com
Ainos director Chun-Jung Tsai sells $53,509 in company stock By Investing.com - Investing.com Canada
Ainos director Lee Ting-Chuan sells $208,977 in stock By Investing.com - Investing.com South Africa
Ainos director Lee Ting-Chuan sells $208,977 in stock - Investing.com
Taiwan Carbon Nano Technology Corp sells $96,760 in Ainos stock By Investing.com - Investing.com Canada
[Form 4] Ainos, Inc. Insider Trading Activity - Stock Titan
Ainos (NASDAQ: AIMD) 10% owner sells 41,000 shares to cover taxes - Stock Titan
Taiwan Carbon Nano Technology Corp sells $96,760 in Ainos stock - Investing.com
Ainos director Chun-Jung Tsai sells $53,509 in company stock - Investing.com
Ainos Inc Stock (AIMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ainos Inc Stock (AIMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| chiang yao-chung | Director |
Jun 03 '26 |
Buy |
2.13 |
2,000 |
4,260 |
7,779 |
| chiang yao-chung | Director |
May 28 '26 |
Buy |
2.30 |
250 |
575 |
5,779 |
| chiang yao-chung | Director |
May 27 '26 |
Buy |
2.00 |
2,000 |
4,000 |
5,529 |
| lee ting-chuan | Director |
May 26 '26 |
Sale |
1.90 |
109,988 |
208,977 |
807,417 |
| Taiwan Carbon Nano Technology | 10% Owner |
May 26 '26 |
Sale |
2.36 |
41,000 |
96,760 |
948,925 |
| TSAI CHUN-JUNG | Director |
May 26 '26 |
Sale |
1.87 |
27,718 |
51,833 |
658,199 |
| TSAI CHUN-JUNG | Director |
May 22 '26 |
Sale |
1.55 |
1,082 |
1,677 |
685,917 |
| lee ting-chuan | Director |
May 22 '26 |
Sale |
1.57 |
9,302 |
14,604 |
917,405 |
| lee ting-chuan | Director |
May 21 '26 |
Sale |
1.56 |
9,000 |
14,040 |
926,707 |
| chiang yao-chung | Director |
May 19 '26 |
Buy |
1.68 |
2,200 |
3,696 |
3,529 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):